Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co., Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. Its offerings include reproductive testing such as PGT-A, niPGT-A, and PGT-M; prenatal testing such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for Down syndrome, risk assessment for early/late-onset preeclampsia, folate metabolism genetic testing, congenital infection screening, carrier scan, thalassemia genetic testing, spinal muscular atrophy genetic testing, and fragile X syndrome genetic testing; and baby genetic testing for sensorineural hearing loss, congenital central hypoventilation syndrome (CCHS), and congenital cytomegalovirus infection (CMV). The company also offers cancer screening services including HPV screening and hereditary cancer testing, develops precision medicine genetic testing, and provides testing services to patients and carriers with rare disorders. Founded in 2012, Sofiva Genomics is based in Taipei, Taiwan.